A new trading day began on Friday, with Krystal Biotech Inc (NASDAQ: KRYS) stock price up 5.48% from the previous day of trading, before settling in for the closing price of $221.96. KRYS’s price has ranged from $122.80 to $222.66 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 109.78%. With a float of $24.87 million, this company’s outstanding shares have now reached $28.98 million.
Krystal Biotech Inc (KRYS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Krystal Biotech Inc is 14.24%, while institutional ownership is 95.50%. The most recent insider transaction that took place on Dec 04 ’25, was worth 5,503,938. In this transaction President, R&D of this company sold 25,000 shares at a rate of $220.16, taking the stock ownership to the 1,413,711 shares. Before that another transaction happened on Dec 04 ’25, when Company’s President, R&D sold 25,000 for $220.14, making the entire transaction worth $5,503,395. This insider now owns 1,483,056 shares in total.
Krystal Biotech Inc (KRYS) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 1.53 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.52 per share during the current fiscal year.
Krystal Biotech Inc (NASDAQ: KRYS) Trading Performance Indicators
Here are Krystal Biotech Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.19. Likewise, its price to free cash flow for the trailing twelve months is 41.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.67, a number that is poised to hit 1.50 in the next quarter and is forecasted to reach 7.63 in one year’s time.
Technical Analysis of Krystal Biotech Inc (KRYS)
Analysing the last 5-days average volume posted by the [Krystal Biotech Inc, KRYS], we can find that recorded value of 0.34 million was better than the volume posted last year of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 90.20%.
During the past 100 days, Krystal Biotech Inc’s (KRYS) raw stochastic average was set at 99.50%, which indicates a significant increase from 98.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 7.35 in the past 14 days, which was higher than the 6.37 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $196.91, while its 200-day Moving Average is $164.73. Now, the first resistance to watch is $238.93. This is followed by the second major resistance level at $243.72. The third major resistance level sits at $252.79. If the price goes on to break the first support level at $225.06, it is likely to go to the next support level at $215.99. Should the price break the second support level, the third support level stands at $211.20.
Krystal Biotech Inc (NASDAQ: KRYS) Key Stats
With a market capitalization of 6.79 billion, the company has a total of 28,998K Shares Outstanding. Currently, annual sales are 290,520 K while annual income is 89,160 K. The company’s previous quarter sales were 97,800 K while its latest quarter income was 79,370 K.
